A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer
about
A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
A Phase I Trial of the IGF-1R ...... Patients with Advanced Cancer
@en
type
label
A Phase I Trial of the IGF-1R ...... Patients with Advanced Cancer
@en
prefLabel
A Phase I Trial of the IGF-1R ...... Patients with Advanced Cancer
@en
P2093
P1433
P1476
A Phase I Trial of the IGF-1R ...... Patients with Advanced Cancer
@en
P2093
Ace J Hatch
Andrew B Nixon
Christel Rushing
Christy C Arrowood
Gordana Vlahovic
Herbert I Hurwitz
Hope E Uronis
Jeffrey Crawford
Jennifer J Meadows
Jingquan Jia
P304
P356
10.1634/THEONCOLOGIST.2016-0377
P50
P577
2018-03-23T00:00:00Z